Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting
August 11, 2023 08:00 ET
|
Bionano Genomics
Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of OGM for clinical research in cancer, featuring cancer genomics experts Dr....
Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress
August 09, 2023 16:01 ET
|
Bionano Genomics
Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022Installed base of Saphyr® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022Sold 7,062...
Bionano Genomics Announces Reverse Stock Split
August 04, 2023 12:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a...
Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023
August 02, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m....
Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company’s Workflow and Helps Build a Community of Users
July 31, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the successful launch of its optical genome mapping (OGM) roadshow, Bionano TOUR, a series of...
Bionano to Present at the Canaccord Genuity 43rd Annual Growth Conference
July 27, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, July 27, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, Ph.D., Bionano’s president and chief executive officer will present at the...
Bionano Announces the Stratys™ System for OGM and VIA™ Software for Hematologic Malignancies
June 29, 2023 17:09 ET
|
Bionano Genomics
The Stratys™ instrument for optical genome mapping (OGM) will enable a four-fold increase in raw data generation rate compared to the Saphyr® instrument. Our plan is to eventually enable labs to...
Bionano to Present at the Healthcare Virtual Conference
June 21, 2023 09:15 ET
|
Bionano Genomics
SAN DIEGO, June 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that the company will participate at the Healthcare Virtual Conference, presented by Maxim Group LLC and...
Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and a 523-gene NGS Panel for Standard Evaluation of Myeloid Cancers
June 20, 2023 08:00 ET
|
Bionano Genomics
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced the publication in Cancers of a peer-reviewed study from Augusta University on the utility of combining...
Bionano Announces Results from its Annual Meeting of Stockholders
June 14, 2023 19:19 ET
|
Bionano Genomics
SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today....